Rosemary Wangensteen Fuentes
Rosemary Wangensteen Fuentes
Adresse e-mail validée de
Citée par
Citée par
Vascular and renal function in experimental thyroid disorders
F Vargas, JM Moreno, I Rodríguez-Gómez, R Wangensteen, A Osuna, ...
European Journal of Endocrinology 154 (2), 197-212, 2006
Nitric oxide synthase activity in hyperthyroid and hypothyroid rats
A Quesada, J Sainz, R Wangensteen, I Rodriguez-Gomez, F Vargas, ...
European Journal of Endocrinology 147 (1), 117-122, 2002
Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility
F Meziani, A Tesse, E David, MC Martinez, R Wangesteen, F Schneider, ...
The American journal of pathology 169 (4), 1473-1483, 2006
Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil
M Galisteo, MF García-Saura, R Jiménez, IC Villar, R Wangensteen, ...
Planta medica 70 (04), 334-341, 2004
Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition
J Sainz, R Wangensteen, IR Gómez, JM Moreno, V Chamorro, A Osuna, ...
American journal of hypertension 18 (6), 871-877, 2005
Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats
I Rodríguez-Gómez, J Sainz, R Wangensteen, JM Moreno, J Duarte, ...
Hypertension 42 (2), 220-225, 2003
Flavonoids in kidney health and disease
F Vargas, P Romecín, AI García-Guillén, R Wangesteen, ...
Frontiers in physiology 9, 394, 2018
Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats
JM Moreno, IR Gómez, R Wangensteen, A Osuna, P Bueno, F Vargas
American Journal of Physiology-Endocrinology and Metabolism 289 (5), E776-E783, 2005
Effects of chronic inhibition of inducible nitric oxide synthase in hyperthyroid rats
I Rodríguez-Gómez, R Wangensteen, JM Moreno, V Chamorro, A Osuna, ...
American Journal of Physiology-Endocrinology and Metabolism 288 (6), E1252-E1257, 2005
Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats
A Quesada, F Vargas, S Montoro-Molina, F O'Valle, ...
PLoS One 7 (7), e40402, 2012
Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice
HR Ranaivo, N Carusio, R Wangensteen, P Ohlmann, C Loichot, A Tesse, ...
The American journal of pathology 170 (2), 439-446, 2007
The renin-angiotensin system: new insight into old therapies
M Ramírez-Sánchez, I Prieto, R Wangensteen, I Banegas, A B Segarra, ...
Current medicinal chemistry 20 (10), 1313-1322, 2013
Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in rats
I Rodriguez-Gomez, I Banegas, R Wangensteen, A Quesada, R Jiménez, ...
J Endocrinol 216 (1), 43-51, 2013
Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition‐induced hypertension
J Sáinz, A Osuna, R Wangensteen, JD Luna, I Rodríguez‐Gómez, ...
Experimental physiology 89 (2), 155-162, 2004
The endocrine system in chronic nitric oxide deficiency
F Vargas, JM Moreno, R Wangensteen, I Rodríguez-Gómez, ...
European journal of endocrinology 156 (1), 1-12, 2007
Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats
JM Moreno, R Wangensteen, J Sainz, I Rodríguez-Gomez, V Chamorro, ...
American Journal of Physiology-Endocrinology and Metabolism 285 (1), E182-E188, 2003
Gender difference in the role of endothelium-derived relaxing factors modulating renal vascular reactivity
R Wangensteen, JM Moreno, J Sainz, I Rodrıguez-Gómez, V Chamorro, ...
European journal of pharmacology 486 (3), 281-288, 2004
Effects of chronic treatment with 7-nitroindazole in hyperthyroid rats
R Wangensteen, I Rodríguez-Gómez, JM Moreno, M Álvarez-Guerra, ...
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2006
Renal vascular reactivity to P2-purinoceptor activation in spontaneously hypertensive rats
O Fernández, R Wangensteen, A Osuna, F Vargas
Pharmacology 60 (1), 47-50, 2000
Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure
G Alvarez, A Osuna, R Wangensteen, F Vargas
Hypertension 35 (3), 752-757, 2000
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20